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Abstract
A systematic review was conducted to identify best practices for increasing linkage, retention and 
re-engagement in HIV care (LRC) for persons living with HIV (PLWH). Our search strategy 
consisted of automated searches of electronic databases and hand searches of journals, reference 
lists and listservs. We developed two sets of criteria: evidence-based to identify evidence-based 
interventions (EBIs) tested with a comparison group and evidence-informed to identify evidence-
informed interventions (EIs) tested with a one-group design. Eligible interventions included being 
published between 1996 and 2014, U.S.-based studies with a comparison or one-group designs 
with pre-post data, international randomized controlled trials, and having objective measures of 
LRC-relevant outcomes. We identified 10 best practices: 5 EBIs and 5 EIs. None focused on re-
engagement. Providers and prevention planners can use the review findings to identify best 
practices suitable for their clinics, agencies, or communities to increase engagement in care for 
PLWH, ultimately leading to viral suppression.
Resumen
Una revisión sistemática se realizó para identificar las mejores prácticas para aumentar la 
vinculación, la permanencia y el regreso hasta atención médica del VIH (VPR) para las personas 
que viven con el VIH (PVVS). La estrategia de búsqueda consistió en búsquedas automatizadas de 
bases de datos electrónicas y búsquedas manuales en revistas, listas de referencias y listas de 
correo electrónico. Hemos desarrollado dos juegos de criterios: “basadas en evidencias” para 
identificar las intervenciones basadas en la evidencia y probadas con un grupo de comparación 
(IBEs), y “informadas por evidencias” para identificar las intervenciones informadas por 
evidencias y probadas con un diseño empleando un solo grupo (IIEs). Intervenciones elegibles 
incluyeron siendo publicados entre 1996 y 2014, estudiados en los Estados Unidos con un grupo 
de comparación o uno grupo con datos pre-post, ensayos internacionales controlados aleatorios, y 
que tienen medidas objetivas de resultados VPR-relevantes. Se identificaron 10 mejores prácticas: 
5 IBEs y 5 IIEs. Ninguno se centró en un regreso hasta atención médica. Los proveedores y los 
planificadores de prevención pueden utilizar los resultados de la revisión para identificar las 
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mejores prácticas adecuadas para sus clínicas, agencias, o comunidades para aumentar la 
participación en la atención médica para las PVVS, en última instancia conduciendo a la supresión 
viral.
Keywords
linkage to HIV care; retention in HIV care; engagement in HIV care; systematic review; evidence-
based interventions; best practices
Palabras clave:
vinculación con la atención médica del VIH; la permanencia en la atención médica del VIH; la 
participación en la atención médica del VIH; revisión sistemática; las intervenciones basadas en la 
evidencia; las mejores prácticas
INTRODUCTION
Being engaged in HIV medical care (e.g., linked to and retained in HIV medical care) is a 
crucial step in achieving viral suppression for persons living with HIV (PLWH) [1]; 
however, recent estimates have indicated only 40% of PLWH are engaged in care [2]. 
Engagement in HIV care has been associated with better health outcomes for PLWH [3, 4] 
and the population as a whole [5, 6] while not being in care or consistent care may 
contribute to poor health outcomes [7, 8], increased mortality [9, 10] and a large percentage 
of new HIV infections [11]. Identifying best practices that may help to increase the 
percentage of PLWH who are linked to, retained and re-engaged in HIV care is urgently 
needed and may contribute to reaching national HIV prevention goals in the National HIV/
AIDS Strategy [1].
Previous systematic reviews on U.S.-based literature on engagement in HIV care 
interventions have synthesized intervention characteristics and study aspects across studies 
[12, 13]. These reviews have been useful for providing an overview of the types of 
interventions tested and used study design to rank studies for strength of evidence. A more 
comprehensive approach that rigorously evaluates individual interventions by examining 
additional domains such as study quality, study implementation, data analysis, as well as 
strength of evidence extends the findings from these previous reviews. Identifying “best 
practices” for linkage to, retention, or re-engagement in HIV care (LRC) using this approach 
provides the field with model programs that have demonstrated low risk of bias and evidence 
of effectiveness.
This article describes the systematic review process implemented by the Centers for Disease 
Control and Prevention’s (CDC) Prevention Research Synthesis Project (PRS) for 
identifying LRC best practices including the evaluation criteria and review methods. The 
paper summarizes the LRC best practices identified as well as discusses LRC interventions 
not meeting best practices criteria. Findings, limitations, and recommendations for future 
research are also discussed.
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METHODS
PRS Best Practices Criteria for LRC Interventions
PRS staff conducted a series of activities to develop LRC best practices criteria within the 
context of an emerging intervention research literature. These activities included multiple 
consultations with CDC scientists, non-federal researchers with expertise in HIV care 
engagement, and a key federal partner – the National Institute of Mental Health (NIMH). 
PRS also used existing efficacy criteria for identifying evidence-based HIV-related risk 
reduction (RR) and medication adherence (MA) interventions as an initial framework and 
adapted the criteria to address issues relevant to engagement in HIV care. PRS criteria are 
consistent with evaluation components used or recommended by groups such as the Agency 
for Healthcare Research and Quality [14], the Cochrane Collaboration [15], The Community 
Guide [16], and Grade of Recommendation, Assessment, Development and Evaluation 
(GRADE) [17].
Given the limited number of controlled trials and the urgent need for identifying best 
practices, PRS developed two sets of criteria to evaluate LRC interventions: evidence-based 
(EB) and evidence-informed (EI) criteria. Figure 1 illustrates the process for deciding which 
set of criteria is used for evaluating studies. EB criteria are used to evaluate LRC 
interventions that have been tested with a comparison group. The EB criteria assess four 
domains: study design quality, study implementation quality, data analysis quality, and 
strength of evidence (specific EB criteria are listed in http://www.cdc.gov/hiv/pdf/
prs_compendium_criteria_for_ebis.pdf, also Appendix 1). LRC interventions meeting all EB 
criteria are identified as Evidence-Based Interventions (EBIs) and provide the strongest 
evidence of efficacy.
The second set of evaluation criteria were developed to evaluate LRC interventions tested 
with one-group study designs that are often used in evaluations of LRC-related programs. 
We labeled this set of criteria as evidence-informed (EI). EI criteria are not as rigorous as 
evidence-based criteria because bias related to selection/allocation, history, or differential 
attribution cannot be appropriately assessed given the one-group study design (specific EI 
criteria are listed in http://www.cdc.gov/hiv/pdf/prs_compendium_criteria_for_eis.pdf, also 
Appendix 2). LRC interventions meeting all EI criteria are identified as Evidence-Informed 
Interventions (EIs).
Systematic Search Strategy
Two librarians developed and conducted a comprehensive and systematic search strategy, 
including both annual automated and quarterly manual searches, to identify all relevant 
engagement in HIV care intervention reports for the PRS cumulative database. The annual 
automated search component focused on literature published from January 1996 using the 
following electronic databases and platforms: CINAHL (EBSCOhost), EMBASE (OVID), 
MEDLINE (OVID), and PsycINFO (OVID). We selected 1996 as the start date for our 
search to be consistent with the year that ART was made more available to persons living 
with HIV in the U.S. The automated search component used indexing and keyword terms, 
cross-referenced employing Boolean logic, in three areas: (a) HIV/AIDS; (b) intervention 
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and prevention evaluation; (c) and engagement in care related terms (e.g., linkage, 
retention). Indexing terms for the electronic searches were varied according to each 
database, but keywords remained constant across all databases and searches. The search was 
not restricted by country or language. The last automated search for this review was 
conducted in May 2014 and covered citations published from January 1996 to December 
2013. The full search strategy of the MEDLINE database is provided in Appendix 3. The 
searches of the other databases are available from the corresponding author.
The quarterly manual search component involved reviewing all articles published in the 
previous 3 months of 60 journals to identify potentially relevant articles not yet indexed in 
electronic databases and examining the reference lists of relevant published articles, HIV/
AIDS Internet listservs, various research databases (i.e., ISI Web of Knowledge, 
RePORTER, Cochrane), and unpublished manuscripts of study authors. The last quarterly 
manual search for this review was conducted in and covered citations published up to 
October 2014. Further details of the quarterly manual search can be obtained from the 
corresponding author.
Study Selection
We searched the PRS database for eligible reports. Reports were included for the LRC best 
practices review if they (1) were published or accepted for publication in a peer-reviewed 
journal between 1996 and October 2014; (2) were conducted in the U.S. or a U.S. territory 
and had a comparison arm or if one-group study design, had pre-post intervention data; (3) 
were conducted outside the U.S. and used a randomized controlled trial study design, (4) 
used relevant measures for LRC outcomes (i.e., HIV medical visits documented in medical 
or agency records, or surveillance reports; HIV viral loads or CD4 counts as proxies for HIV 
medical visits; self-reports validated by medical or agency records, or surveillance reports) 
and (5) reported relevant LRC intervention outcome data (i.e., linkage to, retention in, or re-
engagement in HIV medical care). Linkage to care was defined as the initial HIV medical 
visit for newly- or recently-diagnosed PLWH. Retention in care was broadly defined as 
having two or more HIV medical visits within a specified time period. Re-engagement in 
care was defined as the first HIV medical visit for PLWH who were in care previously, but 
fell out of care. All types of interventions that reported the above outcomes were considered 
(e.g., individual, couple, group, agency, community, structural, policy). Given the LRC 
intervention research literature in the U.S. is still emerging, we increased the pool of eligible 
studies by also including international RCTs, but not international studies with one-group 
pre-post designs. Interpreting findings from one-group pre-post designs conducted in 
international settings is challenging because the results are more susceptible to historical 
events and contextual factors such as local laws and policy changes. We included 
international RCTs because these interventions were evaluated with the most rigorous 
methodology and a comparison arm to reduce potential bias that may result from 
confounders. Exclusion criteria included reports that: a) focused on health care utilization 
(e.g., focused on persons with unknown HIV care histories or reports with outcomes that 
could not be clearly classified as linkage, retention, or re-engagement); b) were non-specific 
to HIV primary care (e.g., emergency room visits, hospitalizations); c) exclusively relied on 
self-reported outcomes; d) did not have pre-intervention data for U.S.-based one-study 
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designs; and e) described pilot studies of full-scale interventions that were included in the 
review.
Qualitative Data Coding
Pairs of trained coders independently evaluated each eligible intervention against the newly 
established best practices criteria on study design, implementation, analysis, and strength of 
findings. The reliability between coders on best practices coding was not calculated. All 
PRS coders go through standardized and stringent coding training and on average, the 
overall percentage agreement among the trained coders is 96% with a kappa rate of 80% on 
our regular citation-level coding, indicating a high inter-rater reliability. All discrepancies 
were reconciled between paired coders. Linked reports, defined as publications providing 
additional information on the same study, were included if they provided relevant 
intervention evaluation information. The first author of individual studies was contacted to 
provide missing data or clarification as needed. Final best practices determination for each 
study was reached by PRS group consensus.
RESULTS
Figure 2 presents the systematic search results. The automated and manual searches yielded 
12,055 reports. After screening titles, abstracts and full reports, we identified 146 
intervention reports with relevant LRC outcomes. Of these, we excluded 122 reports and 
identified 24 eligible interventions. We evaluated 17 interventions (2 for linkage to care, 12 
for retention in care, 3 for both linkage and retention) with evidence-based criteria and 7 
studies with evidence-informed criteria (3 for linkage, 4 for retention). None of the eligible 
studies reported re-engagement outcomes. Ten best practices were identified – five EBIs and 
5 EIs.
Evidence-based Interventions (EBIs)
Study characteristics of the 5 EBIs are presented in Table 1. One EBI found effects for 
linkage [18], one for linkage and retention [19], and three for retention [20–22]. None of the 
EBIs reported re-engagement outcomes. The linkage EBI focused on linking newly 
diagnosed persons to medical care using trained counselors and home visits from 
community support workers in Uganda [18]. The remaining 4 EBIs were U.S.-based. The 
Antiretroviral Treatment Access Study (ARTAS) that provided up to 5 strengths-based case 
management counseling sessions showed significant intervention effects for both linkage 
and retention outcomes among recently diagnosed patients [19]. The other three EBIs that 
demonstrated intervention effects on retention outcomes used different primary intervention 
strategies including co-location of services [21], an interactive notification system to alert 
providers when patients missed appointments [22], and encouraging patients to keep their 
medical visits via in-person and telephone contact [20]. The retention-in-care EBIs, 
including ARTAS, varied in how they measured retention in care. The most common ways 
retention in care was measured were visit constancy (at least one visit in consecutive 
intervals over a specified time period) and kept visits over a specified time period.
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Evidence-Informed Interventions (EIs)
Five U.S.-based interventions were identified as EIs (Table 2). One EI focused on linkage 
[23] while the remaining four EIs focused on retention [24–27]. No EIs reported re-
engagement in care outcomes although one study did include previously-in-care participants 
in the study [27]. The EI that demonstrated intervention effects on the linkage outcome 
implemented a policy of scheduling an orientation visit when new clinic patients called for 
an appointment. Among the four EIs that demonstrated intervention effects on the retention 
outcomes, three exclusively focused on special populations within racial/ethnic minority 
groups such as MSM or young persons. These EIs intervened at both the individual and 
clinic level. At the individual level, examples of strategies included counseling, motivational 
interviewing, case management, providing brief messages on the importance of staying in 
care, and help with appointment scheduling. At the clinic level, strategies included 
displaying posters about the importance of keeping medical appointments in exam and 
waiting rooms, and adding staff that had expertise in or represented the clinic population.
Characteristics of Studies not identified as Best Practices
Fourteen studies were evaluated, but did not meet the best practices criteria. Of these, twelve 
studies did not meet evidence-based criteria (non-EBIs) and two did not meet evidence-
informed criteria (non-EIs). For the non-EBIs, one was a linkage study [28], nine focused on 
retention [29–37] and two reported both linkage and retention outcomes [38, 39]. The most 
common reason for not being identified as an EBI was not having a significant positive 
intervention effect [31–38]. Additional reasons for not meeting evidence-based criteria 
included having outcomes and follow-up assessments that did not occur at a required time 
point [29, 38] or were unclear[28, 30, 39], biased allocation of participants to study arms 
(e.g., comparing two pre-existing groups, researcher pre-selecting a clinic to be an 
intervention arm and another to be the comparison arm) [30, 31, 33, 39], retrospective study 
designs [30, 33, 39], baseline sample sizes less than 40 per arm [29, 33, 34], and non-
appropriate comparison arms (e.g., same intervention, different delivery method) [32, 36]. 
The non-EBIs and EBIs were similar in baseline sample characteristics and study 
characteristics (Table 3). Baseline sample sizes for non-EBIs had a larger range than EBIs. A 
slightly higher percent of non-EBIs focused on persons of color and women compared to 
non-EBIs.
With regard to the non-EIs, the two interventions were HIV testing-related interventions in 
emergency room settings [40, 41]. Neither study found significant intervention effects on the 
change in the number of newly diagnosed persons who were linked to care from pre to post 
implementation of the intervention. One intervention tested routinely recommending HIV 
testing [40] while the other examined a tracking system for HIV testing to flag emergency 
room patients who were at risk for HIV [41]. The most noteworthy difference between the 
two non-EIs and 5 EIs was baseline sample sizes: non-EIs had much smaller sample sizes 
compared to EIs due to the subset of persons testing HIV positive within the larger sample 
of persons tested for HIV.
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DISCUSSION
Given the importance of engaging PLWH in HIV medical care, it is encouraging that we 
identified 10 best practices for the first LRC review. The majority of LRC best practices 
were designed to improve retention in HIV care while a few best practices addressed linkage 
to care. We did not identify any intervention specifically designed for re-engagement in HIV 
care. Re-engaging PLWH who have been in care previously or linking those who may have 
been diagnosed with HIV, but never linked to care may be particularly challenging and 
require intensive intervention strategies. CDC recommends the use of surveillance data to 
identify people who are out of care and re-engage them into HIV care (see Data to Care - 
https://www.effectiveinterventions.org/en/HighImpactPrevention/PublicHealthStrategies/
DatatoCare.aspx). Promising public health strategies may be available for guiding re-
engagement of care activities; however, identifying best practices that successfully link 
never-in-care PLWH or re-engage lost-to-care PLWH remains a crucial need.
Programs that are considering adopting LRC best practices need to consider their resources 
and capacity for successful adoption and implementation. Three EBIs may be especially 
promising for a wider adoption. ARTAS has been successfully implemented and found to be 
effective in most field settings [42]. Intervention materials, training and technical assistance 
for ARTAS are readily available (https://effectiveinterventions.cdc.gov/en/
HighImpactPrevention/PublicHealthStrategies/ARTAS.aspx). The Enhanced Personal 
Contacts intervention has been shown to be relatively low cost to implement [43] and 
interventions can be delivered by trained, non-professional staff. FastTrack, the provider 
notification system that alerts providers when patients miss appointments [22], may be 
viable for clinical settings that have existing patient reminder systems.
Evidence-informed interventions (EIs) can also be considered for implementation in clinic 
settings, but ideally, should be further tested with more rigorous study designs (e.g., using a 
comparison group) or replicated. A majority of the EIs we identified focused on special 
populations of PLWH and included interventionists with expertise in or from special 
populations. Having staff with expertise in or who represent specific patient populations in 
the clinic or other intervention settings may be important in reducing barriers to staying in 
care. Patients may feel more comfortable with their health care providers and agency staff 
and thus, be more likely to keep their medical appointments.
Fourteen studies did not meet best practices criteria, but these studies offer valuable insights. 
For interventions not meeting EB criteria, almost all did not find a significant positive 
intervention effect. Using seemingly “strong” comparison arms in which participants receive 
potent intervention components that go beyond the common standard of clinical care may be 
a plausible reason for this. Minimizing the variability in standard care provided to 
comparison groups may produce more comparable intervention effects across studies [44]. 
Several non-EBIs also had other issues besides not finding significant positive intervention 
effects, such as small sample sizes or not meeting PRS assessment indicators (e.g., within 6 
months for linkage to care and at least 6 months or longer for retention in care). Using 
national indicators for assessing linkage and retention [45] as well as implementing 
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strategies to reduce the risk of bias related to study design [46] would further facilitate 
evaluation of the LRC studies.
Finally, we noted that LRC-related outcome measures varied among the best practices that 
we identified, particularly for retention in care. Although no gold standard yet exists for 
measuring retention in care [47], we encourage researchers and programs to use the Human 
and Health Services (HHS) indicator for retention [45] and follow-up for at least 12 months, 
but strive for a 24-month measurement period. In addition, using other measures of retention 
in care such as missed visits or gaps in care may be important as these measures have been 
found to be highly correlated with viral suppression [47]. The updated NHAS for 2020 
outlines the most recent indicators that the field should consider to meet national HIV 
prevention and care goals [1].
Limitations
Limitations of this review should be mentioned. First, similar to our risk reduction and 
medication adherence efficacy criteria, our best practices criteria for LRC primarily focused 
on internal validity with less emphasis on external validity, cost, and scalability. These 
additional criteria are important parts of high-impact prevention (HIP) [48] and critical for 
deciding which interventions could yield the most impact when they are implemented and 
scaled-up. Although these HIP criteria are not currently part of the best practice criteria, we 
abstracted the information from studies and found few studies that reported the information. 
Measuring and reporting the information about generalizability, cost, and scalability could 
be an important quest. We also found limited information from the published reports to 
provide specific guidelines for implementation. Although general recommendations for 
implementing linkage to and retention in care strategies in clinical and non-clinical settings 
are available in the Updated “Recommendations for HIV prevention with adults and 
adolescents with HIV in the United States”, we strongly encourage more publications and 
information sharing regarding the successful implementation of best practices [49]. Another 
limitation is that we only reviewed studies that meet our inclusion criteria: studies with a 
comparison arm or evaluated with a pre-post design. Observational and correlational studies 
may highlight potential correlates of intervention effects or barriers and facilitators of LRC 
outcomes. Further synthesis of these data could be informative. We also limited this review 
by excluding international one-group studies with pre-post intervention data due to concerns 
about historical factors that are not often properly controlled for in one-group designs and 
may impact the interpretation of study findings. We encourage others to conduct systematic 
reviews of all LRC interventions to identify best practices that are suitable for international 
settings. Finally, we primarily relied on the published literature to identify EBIs and EIs. 
Exploring the grey literature to identify best practices from non-peer reviewed sources 
would potentially expand the portfolio of LRC best practices.
Implications for Future Research
Our best practices review, despite the above limitations, has several implications for further 
research. Mentioned earlier, the most glaring research gap is the lack of best practices 
focused on re-engagement in care. While efforts must be improved to link and retain PLWH 
in care, developing and testing strategies to locate PLWH lost to care and retaining them 
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once they are located needs to be prioritized. We also noted a lack of agreement in 
measuring LRC outcomes, particularly for retention in care. Although no gold standard 
exists for measuring retention in care, we hope the field will adopt a common set of 
indicators to measure LRC outcomes to facilitate evaluation of studies [45, 47]. Another 
implication for future research emerges from our review exclusion criteria. We excluded 
reports that relied only on self-reported data or lacked pre-intervention data. Given the low 
reliability of self-reported LRC outcomes [50], using objective measures of completed 
medical visits in lieu of or in addition to self-report are recommended when evaluating 
programs and conducting future research studies. We also encourage researchers to collect 
pre-intervention data when testing interventions in one-group study designs. Pre-intervention 
data allow for some kind of comparison when assessing the impact of an intervention. 
Finally, although randomized controlled trials may be the gold standard for determining 
intervention efficacy, assessing an intervention’s effectiveness in “real world” settings is also 
important. ARTAS has demonstrated effectiveness when implemented in clinical settings 
[42], but may be less effective with ex-offenders [37]. This kind of information is critical for 
assessing the impact of best practices and strengthening the evidence of best practices. We 
also recommend building research and evaluation capacity for agencies or prevention 
providers doing LRC-related work so they can evaluate their programs that have shown 
some promise, but not yet scientifically evaluated.
Conclusions
The LRC Best Practices review extends previous systematic reviews on engagement in HIV 
care by identifying model programs and promising intervention strategies for promoting 
linkage to, retention and re-engagement in HIV medical care. Providers and other prevention 
planners may use the review findings to identify best practices suitable for their clinics, 
agencies, or communities to increase engagement in care for PLWH, ultimately leading to 
viral suppression. Research gaps identified in our review can further inform the design and 
implementation of LRC studies. Although much work still needs to be done to reach 
national prevention goals related to engaging PLWH in HIV care, this review has identified 
best practices and potential research directions that may help to achieve these goals.
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Figure 1: 
Process for identifying best practices for linkage to, retention and re-engagement in HIV 
medical care
http://www.cdc.gov/hiv/prevention/research/compendium/lrc/bestpractices.html
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Figure 2. 
Study Selection Process and Results
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Table 3
Comparison of characteristics between EBIs and non-EBIs, EIs and non-EIs included in PRS Best Practices 
Review
Characteristics 5 EBIs
n (%)
12 Non-EBIs
n (%)
5 Els
n (%)
2 Non-EIs
n (%)
Outcomes
 Linkage to HIV care 1 (20) 1 (8) 1 (20) 2 (100)
 Retention in HIV care 3 (60) 9 (75) 4 (80) 0
 Both 1 (20) 2 (17) 0 0
 Re-engagement 0 0 0 0
Location
 U.S. 4 (80) 9 (75) 5 (100) 2 (100)
 International 1 (20) 3 (25) NA NA
Primary Setting
 Clinic only 4 (80) 11 (92) 4 (80) 2 (100)
 Clinic & Communityb 1 (20) 1 (9) 1 (20) 0
Specific Population Focusc
 African American/black 0 0 2 (40) 0
 Hispanic/Latino 0 0 3 (60) 0
 Youth or young persons 0 1(9) 2 (40) 0
 MSM 0 0 1 (20) 0
 Women only 0 1(9) 0 0
 Persons with substance use or mental health issues 1(20) 1(9) 0 0
 Recently incarcerated 0 1(9) 0 0
 Veterans 0 1(9) 0 0
Study-Related
 Baseline sample size (min, max) 96,1838 60,10095 43,11039 6, 28a
 Percent Persons of Color (mean) 81% 86% 88% NR
 Percent Women (mean) 36% 48% 22% NR
aSample sizes reflect the number of persons testing HIV positive.
bCommunity-based organizations, field settings
c
Multiple responses possible
EBI = Evidence-based intervention
EI = Evidence-informed intervention
NR = Not reported
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